Results 81 to 90 of about 2,261 (201)

Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.

PLoS ONE, 2023
BackgroundSystemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown origin. The objective of this research was to develop phenotype algorithms for SLE suitable for use in epidemiological studies using empirical evidence from ...
Joel N Swerdel, Darmendra Ramcharran, Jill Hardin   +2 more
doaj   +2 more sources

Ensuring a safe(r) harbor: Excising personally identifiable information from structured electronic health record data

Journal of Clinical and Translational Science, 2022
Recent findings have shown that the continued expansion of the scope and scale of data collected in electronic health records are making the protection of personally identifiable information (PII) more challenging and may inadvertently put our ...
Emily R. Pfaff, Melissa A. Haendel, Kristin Kostka, Adam Lee, Emily Niehaus, Matvey B. Palchuk, Kellie Walters, Christopher G. Chute   +7 more
doaj   +1 more source

Similar risk of kidney failure among patients with blinding diseases who receive ranibizumab, aflibercept, and bevacizumab: an OHDSI Network Study

Ophthalmology Retina
Objective or Purpose: A) To characterize the incidence of kidney failure associated with intravitreal anti-vascular endothelial growth factor (VEGF) exposure, and B) compare the risk of kidney failure in patients treated with ranibizumab, aflibercept, or
C. Cindy, Akihiko Nishimura, M. Bowring, Erik Westlund, Diep Tran, J. H. Ng, Paul Nagy, Michael Cook, Jody-Ann McLeggon, Scott L. DuVall, M. Matheny, A. Golozar, A. Ostropolets, Evan P. Minty, Priya Desai, F. Bu, Brian C. Toy, Michelle Hribar, T. Falconer, Linying Zhang, Laurence Lawrence-Archer, Michael V. Boland, Kerry E. Goetz, Nathan Hall, A. Shoaibi, Jenna M. Reps, A. Sena, C. Blacketer, J. Swerdel, K. Jhaveri, Edward Lee, Zachary D. Gilbert, S. Zeger, Deidra C. Crews, M. Suchard, G. Hripcsak, Patrick B. Ryan   +36 more
semanticscholar   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Mental Health Disorders in Type 2 Diabetes: Active Comparator, New User Cohort Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 9, Page 8482-8493, September 2026.
ABSTRACT Aims We evaluated the risk of mental health disorders among glucagon‐like peptide‐1 receptor agonist (GLP1RA) users compared with users of dipeptidyl peptidase‐4 (DPP‐4) inhibitors and sodium‐glucose cotransporter‐2 (SGLT2) inhibitors. Materials and Methods We conducted a nationwide, active‐comparator new‐user cohort study using the Korean ...
Chungsoo Kim, Seonji Kim, Dong Yun Lee, Eugene Han, Yong‐ho Lee, Seng Chan You   +5 more
wiley   +1 more source

OHDSI/PhenotypeLibrary: Release v3.20.0

, 2023
<p>See NEWS.md for release notes.</p ...
Gowtham Rao
core   +1 more source

Frequency and Timing of Depression and Anxiety Diagnoses Following Cancer Diagnosis: A Multi‐Center Cohort Study

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Depression and anxiety are common among individuals with cancer and are associated with adverse outcomes; however, the frequency, timing, and disparities of anxiety and depression diagnoses following cancer diagnosis remain incompletely characterized.
Suraj Manohar Rajan, Vivian Tran, Aaron‐john Lee, Carol Y. Ochoa‐Dominguez, Joshua Demb, Melody K. Schiaffino, Edmund Qiao, Tyler Seibert, James Murphy, Brent Rose, Matthew P. Banegas   +10 more
wiley   +1 more source

OHDSI/PhenotypeLibrary: Release v3.22.0

, 2023
<p>See NEWS.md for release notes.</p ...
Gowtham Rao
core   +1 more source

Towards global model generalizability: independent cross-site feature evaluation for patient-level risk prediction models using the OHDSI network

J. Am. Medical Informatics Assoc.
BACKGROUND Predictive models show promise in healthcare, but their successful deployment is challenging due to limited generalizability. Current external validation often focuses on model performance with restricted feature use from the original training
Behzad Naderalvojoud, C. Curtin, C. Yanover, T. El-Hay, B. Choi, Rae Woong Park, Javier Gracia Tabuenca, M. Reeve, T. Falconer, Keith Humphreys, Steven M. Asch, T. Hernandez-Boussard   +11 more
semanticscholar   +1 more source

Adherence and Persistence Among Individuals Living With Type 2 Diabetes and Using a Free Combination of Basal Insulin and an Injectable Glucagon‐Like Peptide‐1 Receptor Agonist Versus a Fixed‐Ratio Combination Therapy: A Japanese Database Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6291-6300, July 2026.
ABSTRACT Aim To investigate adherence to and persistence with free combination therapy (daily basal insulin plus an injectable glucagon‐like peptide‐1 receptor agonist [GLP‐1 RA]) versus fixed‐ratio combination (FRC) therapy (basal insulin plus a GLP‐1 RA) among individuals with type 2 diabetes (T2D) in Japan.
Takeshi Miyatsuka, James Brash, Eleanor Davies, Elisabeth de Laguiche, Dorte Vistisen, Can Yin, Atif Adam   +6 more
wiley   +1 more source

roux-ohdsi/allofus: allofus 1.0.0

, 2023
<p>Initial release</p ...
Louisa Smith, Rob Cavanaugh
core   +1 more source